User menu

Expression of vasoactive intestinal peptide and related receptors in overcirculation-induced pulmonary hypertension in piglets.

Bibliographic reference Vuckovic, Aline ; Rondelet, Benoît ; Brion, Jean-Pierre ; Naeije, Robert. Expression of vasoactive intestinal peptide and related receptors in overcirculation-induced pulmonary hypertension in piglets.. In: Pediatric Research : international journal of human developmental biology, Vol. 66, no.4, p. 395-399 (2009)
Permanent URL
  1. Farber Harrison W., Loscalzo Joseph, Pulmonary Arterial Hypertension, 10.1056/nejmra035488
  2. Vaudry D, Pharmacol Rev, 52, 269 (2000)
  3. Henning R, Vasoactive intestinal peptide: cardiovascular effects, 10.1016/s0008-6363(00)00229-7
  4. Petkov Ventzislav, Mosgoeller Wilhelm, Ziesche Rolf, Raderer Markus, Stiebellehner Leopold, Vonbank Karin, Funk Georg-Christian, Hamilton Gerhard, Novotny Clemens, Burian Bernhard, Block Lutz-Henning, Vasoactive intestinal peptide as a new drug for treatment of primary pulmonary hypertension, 10.1172/jci17500
  5. Janosi Tibor, Peták Ferenc, Fontao Fabienne, Morel Denis R., Beghetti Maurice, Habre Walid, Differential roles of endothelin-1 ETAand ETBreceptors and vasoactive intestinal polypeptide in regulation of the airways and the pulmonary vasculature in isolated rat lung : Bronchial and vascular effects of endothelin-1 receptor blockers and VIP, 10.1113/expphysiol.2008.042481
  6. TOUBAS P. L., SEKAR K. C., SHELDON R. E., PAHLAVAN N., SAID S. I., Vasoactive Intestinal Peptide Prevents Increase in Pulmonary Artery Pressure during Hypoxia in Newborn Lambs, 10.1111/j.1749-6632.1988.tb27043.x
  7. Cox C.P., Linden J., Said S.I., VIP elevates platelet cyclic AMP (cAMP) levels and inhibits in vitro platelet activation induced by platelet-activating factor (PAF), 10.1016/0196-9781(84)90228-6
  8. Minkes RK, J Appl Physiol, 72, 1212 (1992)
  9. Said SI, Circulation, 115, 1260 (2007)
  10. Otto C., Pulmonary Hypertension and Right Heart Failure in Pituitary Adenylate Cyclase-Activating Polypeptide Type I Receptor-Deficient Mice, 10.1161/01.cir.0000147235.53360.59
  11. Rondelet B., Bosentan for the Prevention of Overcirculation-Induced Experimental Pulmonary Arterial Hypertension, 10.1161/01.cir.0000053443.27512.33
  12. Winer Jane, Jung Christopher Kwang S., Shackel Irene, Williams P.Mickey, Development and Validation of Real-Time Quantitative Reverse Transcriptase–Polymerase Chain Reaction for Monitoring Gene Expression in Cardiac Myocytesin Vitro, 10.1006/abio.1999.4085
  13. Hsu Su-Ming, [39] Immunohistochemistry, Avidin-Biotin Technology (1990) ISBN:9780121820855 p.357-363, 10.1016/0076-6879(90)84293-p
  14. Rondelet B., Signaling Molecules in Overcirculation-Induced Pulmonary Hypertension in Piglets: Effects of Sildenafil Therapy, 10.1161/01.cir.0000143836.40431.f5
  15. Rondelet Benoit, Kerbaul François, Vivian Gabriela Flores, Hubloue Ives, Huez Sandrine, Fesler Pierre, Remmelink Myriam, Brimiouille Serge, Salmon Isabelle, Naeije Robert, Sitaxsentan for the Prevention of Experimental Shunt-Induced Pulmonary Hypertension, 10.1203/pdr.0b013e318030d169
  16. SAID SAMI I., Vasoactive Intestinal Peptide in the Lung, 10.1111/j.1749-6632.1988.tb26999.x
  17. Busto Rebeca, Prieto Juan C, Bodega Guillermo, Zapatero José, Carrero Isabel, Immunohistochemical localization and distribution of VIP/PACAP receptors in human lung☆, 10.1016/s0196-9781(99)00202-8
  18. Taylor C R, Levenson R M, Quantification of immunohistochemistry?issues concerning methods, utility and semiquantitative assessment II, 10.1111/j.1365-2559.2006.02513.x
  19. Asnicar Mark A., Köster Anja, Heiman Mark L., Tinsley Frank, Smith Dennis P., Galbreath Elizabeth, Fox Niles, Ma Yanfei Linda, Blum Werner F., Hsiung Hansen M., Vasoactive Intestinal Polypeptide/Pituitary Adenylate Cyclase-Activating Peptide Receptor 2 Deficiency in Mice Results in Growth Retardation and Increased Basal Metabolic Rate, 10.1210/en.2002-220354
  20. Anaid Shahbazian, Petkov Ventzislav, Baykuscheva-Gentscheva Temenuschka, Hoeger Harald, Painsipp Evelin, Holzer Peter, Mosgoeller Wilhelm, Involvement of endothelial NO in the dilator effect of VIP on rat isolated pulmonary artery, 10.1016/j.regpep.2006.10.012
  21. Gratton J.-P., Cournoyer G., Loffler B.-M., Sirois P., D'Orleans-Juste P., ETB Receptor and Nitric Oxide Synthase Blockade Induce BQ-123 Sensitive Pressor Effects in the Rabbit, 10.1161/01.hyp.30.5.1204
  22. de Nucci G., Thomas R., D'Orleans-Juste P., Antunes E., Walder C., Warner T. D., Vane J. R., Pressor effects of circulating endothelin are limited by its removal in the pulmonary circulation and by the release of prostacyclin and endothelium-derived relaxing factor., 10.1073/pnas.85.24.9797
  23. Pitts Richard L., Wang Shuibang, Jones Elizabeth A., Symes Aviva J., Transforming Growth Factor-β and Ciliary Neurotrophic Factor Synergistically Induce Vasoactive Intestinal Peptide Gene Expression through the Cooperation of Smad, STAT, and AP-1 Sites, 10.1074/jbc.m011759200
  24. Du Lingling, Sullivan Christopher C., Chu Danny, Cho Augustine J., Kido Masakuni, Wolf Paul L., Yuan Jason X.-J., Deutsch Reena, Jamieson Stuart W., Thistlethwaite Patricia A., Signaling Molecules in Nonfamilial Pulmonary Hypertension, 10.1056/nejmoa021650
  25. Hamidi S. A., Prabhakar S., Said S. I., Enhancement of pulmonary vascular remodelling and inflammatory genes with VIP gene deletion, 10.1183/09031936.00105807